Diligence memo · auto-generated · as of July 2, 2026

US Chemical Technologies, Inc.

US Chemical Technologies, Inc. looks fair against its niche peers and is active on financing cadence.

SourceRaising on rhythm with a 2.7× step-up on the last round — momentum worth tracking before it's priced in.

Businessfiled

US Chemical Technologies, Inc. operates in Software / Tech, based in WASHINGTON.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

US Chemical Technologies, Inc. has raised $41M in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Series B (a $15M–$40M round).

Largest single filing: $30M on 2026-01-09.

Most recent recorded round closed around 2026-01-09.

Valuation (modeled)modeled

Provath models US Chemical Technologies, Inc. at approximately $131M (range $73M–$176M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Fair. Modeled value is 1.32× the median modeled value of Series B Software / Tech companies in 2025–2027 (95 peers) — value vs value, same stage and era. Within the normal band (132% of peer median) for its niche.

Financing rhythm & timingmixed

Historic cadence: a new round about every 7 months.

Last raise 6 mo ago; this sector typically re-raises about every 13 months.

Raising on or ahead of the sector's normal rhythm.

The last round stepped up 2.7× from the prior — scaling.

Comparablesmixed

Capital scale ranks ahead of 89% of Software / Tech peers (3920 compared).

Modeled value ranks above 77% of those peers.

Closest niche peers: Machina Labs, Inc., Metaview Technologies Inc., Felix Technologies Inc., Foxglove Technologies Inc., NetBox Labs, Inc..

Peoplefiled

4 named people on file across officers, directors and signatories.

Risks & flagsmixed

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.